Among new findings is the link between 12 different cancers inside the human genome that researchers hope will explain some of the key drivers of the disease.
Matthew Webster, a 34-year-old engineer from Newcastle, who has had his life changed due to targeted cancer treatments.
Mr Webster was diagnosed with a rare cancer called Angiomatoid Fibrous Histiocytoma at the age of 24.
These rare cancers make up one in five cancer deaths in Australia.

He went through surgery, chemotherapy and other conventional treatments before he learned of the field of personalised or precision medicine, which uses an understanding of a person's DNA and genome to tailor treatments.
Mr Webster initially travelled to Germany for the treatment which was not available in Australia, but he was then able to access treatment back home through Professor David Thomas who founded the not-for-profit genomics organisation Omico.
Listen to SBS Indonesian every Monday, Wednesday, Friday, and Sunday at 3 pm.
Follow us on Facebook and Instagram, and listen to our podcasts.




